Literature DB >> 8063387

Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B.

A Norrby-Teglund1, M Norgren, S E Holm, U Andersson, J Andersson.   

Abstract

The cytokine production induced by a newly discovered streptococcal exotoxin, MF, and the pyrogenic exotoxins SpeA and SpeB was determined by in vitro stimulation of peripheral blood mononuclear cells (PBMCs) obtained from healthy blood donors. The induction and kinetics of interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-1 receptor antagonist, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-10, gamma interferon, tumor necrosis factor alpha (TNF-alpha), TNF-beta, and granulocyte-macrophage colony-stimulating factor were studied at the single-cell level by use of cytokine-specific monoclonal antibodies and intracellular immunofluorescent juxtanuclear staining. The cytokine-producing cells, with the exception of IL-1-expressing cells, had a characteristic morphology generated by the accumulation of cytokines in the Golgi organelle. MF, SpeA, and SpeB induced a massive gamma interferon and TNF-beta response in 10 to 16% of the PBMCs after 48 to 96 h of cell stimulation. In contrast, IL-2 and TNF-alpha production was detected in only 1 to 3% of the PBMCs. The induction of a lymphocyte TH2 phenotype response, including production of IL-3, IL-4, IL-5, and IL-10, was weak. However, the monokines, IL-1 alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8, were consistently found and gradually produced, peaking at 24 h in approximately 5 to 8% of the PBMCs. MF showed extensive cytokine- and proliferation-inducing capacities equal to those of SpeA and SpeB, which suggests that MF is also a superantigen. A marked interindividual variation could be noted both in the proliferative response and in the cytokine induction of lymphocytes isolated from different individuals, which may be one explanation for the varying clinical severity noticed during group A streptococcal infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063387      PMCID: PMC303024          DOI: 10.1128/iai.62.9.3731-3738.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Heterogeneity of group A streptococcal pyrogenic exotoxin type B.

Authors:  E L Barsumian; C M Cunningham; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

3.  Purification and characterization of group A streptococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion.

Authors:  L P Johnson; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

6.  Mouse lymphotoxin and tumor necrosis factor: structural analysis of the cloned genes, physical linkage, and chromosomal position.

Authors:  S M Gardner; B A Mock; J Hilgers; K E Huppi; W D Roeder
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

7.  Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.

Authors:  T Uchiyama; Y Kamagata; X J Yan; M Kohno; M Yoshioka; H Fujikawa; H Igarashi; M Okubo; F Awano; T Saito-Taki
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

8.  Human interleukin 6 and tumor necrosis factor alpha production studied at a single-cell level.

Authors:  U Andersson; T Matsuda
Journal:  Eur J Immunol       Date:  1989-06       Impact factor: 5.532

9.  [Purification and characterization of erythrogenic toxins. I. Investigation of erythrogenic toxin A produced by Streptococcus pyogenes strain NY-5 (author's transl)].

Authors:  D Gerlach; H Knöll; W Köhler
Journal:  Zentralbl Bakteriol A       Date:  1980

10.  Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.

Authors:  M C Cuturi; M Murphy; M P Costa-Giomi; R Weinmann; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  22 in total

1.  Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C.

Authors:  J Yamaoka; E Nakamura; Y Takeda; S Imamura; N Minato
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 2.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

3.  Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.

Authors:  M Roggiani; J A Stoehr; B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.

Authors:  Y Kamezawa; T Nakahara; S Nakano; Y Abe; J Nozaki-Renard; T Isono
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

5.  Lipopolysaccharide triggers invasive streptococcal disease in mice through a tumour necrosis factor-alpha-dependent mechanism.

Authors:  Hongyan Diao; Masashi Kohanawa; Hirofumi Nakajima; Yuichiro Sato; Tomonori Minagawa; Akio Nakane
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

6.  Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.

Authors:  H Basma; A Norrby-Teglund; A McGeer; D E Low; O El-Ahmedy; J B Dale; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 7.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

8.  Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.

Authors:  H Basma; A Norrby-Teglund; Y Guedez; A McGeer; D E Low; O El-Ahmedy; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells.

Authors:  M Miettinen; S Matikainen; J Vuopio-Varkila; J Pirhonen; K Varkila; M Kurimoto; I Julkunen
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.